MTOR and nonpapillary renal cell carcinoma: Besides, ZZDHHC2 mediates AGK’s S-palmitoylation, promoting its translocation to the plasma membrane and activation of the PI3K-AKT-mTOR pathway in ccRCC, thereby modulating sunitinib sensitivity.